Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Steven W. Heiner"'
Autor:
Mary J. Malloy, Irina Movsesyan, Ira D. Goldfine, Andrew A. Bremer, John P. Kane, Uǧur Hodoglugil, Clive R. Pullinger, Ed.D. Steven W. Heiner, Sinan Tanyolaç
Publikováno v:
Metabolic Syndrome and Related Disorders. 7:543-548
Hypertriglyceridemia is associated with insulin resistance, type 2 diabetes, and the metabolic syndrome. Membrane glycoprotein PC-1 (also termed ENPP1) is a direct insulin receptor inhibitor, and certain polymorphisms of the ENPP1/PC-1 gene have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c14f06f124d1b7af6690affb8411da
https://doi.org/10.1089/met.2009.0027
https://doi.org/10.1089/met.2009.0027
Autor:
Eusebio, Chiefari, Sinan, Tanyolaç, Francesco, Paonessa, Clive R, Pullinger, Carmelo, Capula, Stefania, Iiritano, Tommaso, Mazza, Michele, Forlin, Alfredo, Fusco, Vincent, Durlach, Anne, Durlach, Mary J, Malloy, John P, Kane, Steven W, Heiner, Mirella, Filocamo, Daniela P, Foti, Ira D, Goldfine, Antonio, Brunetti
Publikováno v:
JAMA. 305(9)
High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes mellitus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ceebc1935022d9aa8ae80954fe6c4bb
https://pubmed.ncbi.nlm.nih.gov/21364145
https://pubmed.ncbi.nlm.nih.gov/21364145
Autor:
John P. Kane, Anne Durlach, Antonio Brunetti, Daniela Foti, Mary J. Malloy, Steven W. Heiner, Francesco Paonessa, Ira D. Goldfine, Alfredo Fusco, Carmelo Capula, Michele Forlin, Tommaso Mazza, V. Durlach, Clive R. Pullinger, Eusebio Chiefari, Mirella Filocamo, Sinan Tanyolaç, Stefania Iiritano
Publikováno v:
JAMA. 305:903
Context High-mobility group A1 (HMGA1) protein is a key regulator of insulin receptor (INSR) gene expression. We previously identified a functional HMGA1 gene variant in 2 insulin-resistant patients with decreased INSR expression and type 2 diabetes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8680544329e559bdc682551d8bfc31d1
https://doi.org/10.1001/jama.2011.207
https://doi.org/10.1001/jama.2011.207
Autor:
Sinan Tanyolaç, Andrew A. Bremer, Uur Hodoglugil, Irina Movsesyan, Clive R. Pullinger, Steven W. Heiner, Mary J. Malloy, John P. Kane, Ira D. Goldfine
Publikováno v:
Metabolic Syndrome & Related Disorders; Dec2009, Vol. 7 Issue 6, p543-548, 6p